Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration.
Mihai Avram, Felix Müller, Katrin H Preller, Adeel Razi, Helena Rogg, Alexandra Korda, Friederike Holze, Patrick Vizeli, Laura Ley, Matthias E Liechti, Stefan Borgwardt
Biological psychiatry. Cognitive neuroscience and neuroimaging May 1, 2024 DOI: 10.1016/j.bpsc.2023.07.010 via PubMed
Summary
AI-generated from the abstractIn a double-blind, placebo-controlled, crossover study with 25 healthy participants, LSD, MDMA, and d-amphetamine all increased effective connectivity from the thalamus to specific unimodal cortices while reducing the influence of those cortices back onto the thalamus, indicating stronger bottom-up and weaker top-down information flow. For transmodal cortices, including parts of the salience network, amphetamines showed opposite effects. LSD uniquely increased effective connectivity from the thalamus to both unimodal and transmodal cortices, suggesting a breakdown in the hierarchical organization of brain activity. These findings refine models of how psychedelics alter brain connectivity.
Study at a glance
| Characteristics | Double-blind, placebo-controlled, crossover design Peer reviewed |
|---|---|
| Sample size | 25 |
| Population | Healthy participants |
| Interventions | LSD MDMA d-amphetamine |
| Topics | LSD MDMA |
| Keywords | Dynamic causal modeling Effective connectivity Psychedelics |
| Citations | 13 |
| Key finding | LSD increased effective connectivity from the thalamus to both unimodal and transmodal cortices, indicating a breach in hierarchical brain organization, whereas amphetamines showed opposite effects for transmodal cortices. |
Abstract
While the exploration of serotonergic psychedelics as psychiatric medicines deepens, so does the pressure to better understand how these compounds act on the brain. We used a double-blind, placebo-controlled, crossover design and administered lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), and d-amphetamine in 25 healthy participants. By using spectral dynamic causal modeling, we mapped substance-induced changes in effective connectivity between the thalamus and different cortex types (unimodal vs. transmodal) derived from a previous study with resting-state functional magnetic resonance imaging data. Due to the distinct pharmacological modes of action of the 3 substances, we were able to investigate specific effects mainly driven by different neurotransmitter systems on thalamocortical and corticothalamic interactions. Compared with placebo, all 3 substances increased the effective connectivity from the thalamus to specific unimodal cortices, whereas the influence of these cortices on the thalamus was reduced. These results indicate increased bottom-up and decreased top-down information flow between the thalamus and some unimodal cortices. However, for the amphetamines, we found the opposite effects when examining the effective connectivity with transmodal cortices, including parts of the salience network. Intriguingly, LSD increased the effective connectivity from the thalamus to both unimodal and transmodal cortices, indicating a breach in the hierarchical organization of ongoing brain activity. The results advance our knowledge about the action of psychedelics on the brain and refine current models aiming to explain the underlying neurobiological processes.